Explore Autolus Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for AUTL.

Autolus Therapeutics Stock Price, Quotes and Forecasts | NASDAQ:AUTL | Benzinga

AUTOLUS THERAPEUTICS PLC

Autolus Therapeutics

Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8.

Stock market analysts

News

Upgrades

Pre-Market Outlook

Markets

Analyst Ratings

Trading Ideas

AUTL

KLIC

This InterContinental Hotels Analyst Turns Bullish; Here Are Top 5 Upgrades For Friday

Nvidia Corporation (NVDA)

Price Target

IHRT

MNDY

NVDA

PHUN

SAIA

Nvidia To Rally Around 14%? Here Are 10 Top Analyst Forecasts For Tuesday

Nvidia, Palantir, Clover Health, Joby Aviation, Tesla: Why These 5 Stocks Are On Investors' Radars Today

Movers

COIN

DWTX

DXYZ

FOXO

FRES

HOVR

JTAI

LICY

LWAY

MARA

PITA

REVB

SPPL

Why Revelation Biosciences Shares Are Trading Higher By Around 49%; Here Are 20 Stocks Moving Premarket

Autolus Therapeutics plc - American Depositary Shares

Autolus Therapeutics PLC

Austal Ltd

Earnings

Press Releases

Autolus Therapeutics Reports Third Quarter 2024 Financial Results and Business Updates

Autolus Therapeutics Announces Publication of Data from the FELIX study of obe-cel in r/r Adult B-ALL Patients in The New England Journal of Medicine

Autolus Therapeutics Presents Clinical Data Updates at the American Society of Hematology (ASH) Annual Meeting 2024

Autolus Therapeutics Provides Business Updates and 2025 Overview

Autolus Therapeutics Presents Clinical Data Updates at the 2025 Tandem Meetings

Autolus Therapeutics to Participate in Upcoming Investor Conferences

Autolus Therapeutics to Report Fourth Quarter 2024 Financial Results and Host Conference Call on March 20, 2025

Autolus Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Business Updates

Autolus Therapeutics to Host R&D Investor Event on Wednesday, April 23, 2025

Autolus Therapeutics to Participate in the 24th Annual Needham Virtual Healthcare Conference

Abivax

Akebia Therapeutics

Capricor Therapeutics, Inc. - Common Stock

Capricor Therapeutics

Celcuity

Cullinan Therapeutics, Inc. - Common Stock

Cullinan Therapeutics

Erasca

Immatics

Keros Therapeutics

Kura Oncology

MeiraGTx Hldgs

Mereo BioPharma Group plc - American Depositary Shares

Mereo BioPharma Group

Oric Pharmaceuticals, Inc. - Common Stock

ORIC Pharmaceuticals

Oruka Therapeutics

Precigen

PureTech Health plc - American Depositary Shares

PureTech Health

Regenxbio

Relay Therapeutics

Sage Therapeutics

Sana Biotechnology

Stoke Therapeutics

Savara

Tourmaline Bio

Tyra Biosciences

Upstream Bio

Verve Therapeutics

Truist Securities

Wells Fargo

Needham

Goldman Sachs

Redburn Atlantic

Learn About Cryptocurrency

acf/sidebar-related-posts

Learn about this leading blockchain platform that supports decentralized applications and smart contracts.

What is Ethereum?

Earning interest on your Ethereum is a great way to grow your cryptocurrency holdings. Find out how to earn interest on your Ethereum in 4 easy steps.

How to Earn Interest on Ethereum

Discover the 10 best cryptocurrencies to invest in for January 2025. Stay ahead in the crypto market with our expert insights and analysis! Learn more now!

10 Best Cryptocurrencies to Invest In for April 2025

10 Best Cryptocurrencies to Invest in for January 2025

Discover the best altcoins to invest in for high potential returns. Our top altcoin picks include Ethereum, Solana, Ripple, Dogecoin, Toncoin.

Top 10 Best Altcoins • Benzinga Crypto

10 Best Altcoins in November 2024

Top Cryptocurrency News

acf/news-feed

Future Finance Newsletter

acf/page-sidebar-placement

Cryptocurrency /Money Sidebar

Application error: a client-side exception has occurred (see the browser console for more information).